Pulmonary Fibrosis Caused by Severe COVID-19 Infection: Discharge May Not Be The End of Treatment
Since December 2019, COVID-19 caused by SARS-CoV-2 infection has been spread rapidly in the world. Beside acute respiratory distress syndrome found in acute phase of infection, there is also pulmonary fibrosis as a chronic complication due to COVID-19. With the global pandemic of COVID-19, more and...
Main Author: | Cleopas Martin Rumende |
---|---|
Format: | Article |
Language: | English |
Published: |
Interna Publishing
2021-07-01
|
Series: | Acta Medica Indonesiana |
Subjects: | |
Online Access: | https://www.actamedindones.org/index.php/ijim/article/view/1838 |
Similar Items
-
Clinicopathological Outlines of Post-COVID-19 Pulmonary Fibrosis Compared with Idiopathic Pulmonary Fibrosis
by: Roxana-Elena Cîrjaliu, et al.
Published: (2023-06-01) -
Destructive pulmonary fibrosis after severe COVID-19 pneumonia
by: Alice Letellier, et al.
Published: (2020-11-01) -
Severe pulmonary hypertension due to combined pulmonary fibrosis and emphysema: another cause of death among smokers
by: André Carramenha de Góes Hirano, et al.
Published: (2017-06-01) -
COVID-19 Infection May Drive EC-like Myofibroblasts towards Myofibroblasts to Contribute to Pulmonary Fibrosis
by: Xiuju Wu, et al.
Published: (2023-07-01) -
Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in a Prospective Registry of Interstitial Lung Diseases in Eastern Siberia
by: Maria S. Nashatyreva, et al.
Published: (2023-01-01)